Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca wins damages in Prilosec patent litigation


Wednesday, 4 Dec 2013 07:00pm EST 

AstraZeneca PLC:Says the US District Court for the Southern District of New York ordered Apotex Corp., Apotex, Inc and Torpharm, Inc. (Apotex) to pay AstraZeneca about $76 million in damages.Says the ruling is a result of Apotex's infringing sales of generic omeprazole between 2004 and 2007.Says this follows a previous ruling in 2007 that found two Prilosec (omeprazole) formulation patents valid and infringed by Apotex.